Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akin Akinc

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Cell Host & Microbe|September 10, 2008
Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infectionCristina D Rodrigues, Michael Hannus, Miguel Prudêncio, et al.
Angewandte Chemie (International Ed. in English)|July 12, 2012
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivoMuthusamy Jayaraman, Steven M Ansell, Barbara L Mui, et al.
The New England Journal of Medicine|July 11, 2017
Targeting of Antithrombin in Hemophilia A or B with RNAi TherapyK John Pasi, Savita Rangarajan, Pencho Georgiev, et al.
Nature|November 13, 2004
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAsJürgen Soutschek, Akin Akinc, Birgit Bramlage, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Lipid-like materials for low-dose, in vivo gene silencingKevin T Love, Kerry P Mahon, Christopher G Levins, et al.
Nucleic Acids Research|October 6, 2017
Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc-siRNA conjugatesJayaprakash K Nair, Husain Attarwala, Alfica Sehgal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2010
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanismsAkin Akinc, William Querbes, Soma De, et al.
Journal of the American Chemical Society|December 2, 2014
Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencingJayaprakash K Nair, Jennifer L S Willoughby, Amy Chan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 27, 2013
Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeuticsMartin A Maier, Muthusamy Jayaraman, Shigeo Matsuda, et al.
Nature Medicine|April 8, 2015
An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophiliaAlfica Sehgal, Scott Barros, Lacramioara Ivanciu, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Cell Host & Microbe|September 10, 2008
Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infectionCristina D Rodrigues, Michael Hannus, Miguel Prudêncio, et al.
Angewandte Chemie (International Ed. in English)|July 12, 2012
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivoMuthusamy Jayaraman, Steven M Ansell, Barbara L Mui, et al.
The New England Journal of Medicine|July 11, 2017
Targeting of Antithrombin in Hemophilia A or B with RNAi TherapyK John Pasi, Savita Rangarajan, Pencho Georgiev, et al.
Nature|November 13, 2004
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAsJürgen Soutschek, Akin Akinc, Birgit Bramlage, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Lipid-like materials for low-dose, in vivo gene silencingKevin T Love, Kerry P Mahon, Christopher G Levins, et al.
Nucleic Acids Research|October 6, 2017
Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc-siRNA conjugatesJayaprakash K Nair, Husain Attarwala, Alfica Sehgal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2010
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanismsAkin Akinc, William Querbes, Soma De, et al.
Journal of the American Chemical Society|December 2, 2014
Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencingJayaprakash K Nair, Jennifer L S Willoughby, Amy Chan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 27, 2013
Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeuticsMartin A Maier, Muthusamy Jayaraman, Shigeo Matsuda, et al.
Nature Medicine|April 8, 2015
An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophiliaAlfica Sehgal, Scott Barros, Lacramioara Ivanciu, et al.
Pageof 5